Global Immunohistochemistry Market Outlook: Ken Research

 Immunohistochemistry (IHC), is a major application of polyclonal and monoclonal antibodies which makes to recognize the tissue distribution of an antigen. It is utilized in the identification of antigens, tumour cell proliferation, enzymes and tumour suppressor genes. Immunohistochemical staining is extensively used in the treatment of abnormal cells like as found in cancerous tumours. Certain molecular markers are characteristic of definite cellular events like proliferation or death of cell also known as apoptosis. Further, immunohistochemistry is widely used in ultra-critical research to recognize the circulation and localization of biomarkers and differentially expressed proteins in different parts of biological tissue. Rising prevalence of chronic diseases like cancer, cardiovascular, etc., raising drug discovery and development activities and the launch of technologically advanced immunohistochemistry solutions are some factors accountable for high CAGR of the market during the forecast amount.

The report interpretation of,’ Global Immunohistochemistry Market is valued approximately at USD 1.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.5% over the forecast period 2020-2026’ The global market for immunohistochemistry demonstrates a highly competitive business landscape with a significantly high number of participants Danaher Corporation, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., PerkinElmer, Inc., Abcam PLC, Cell Signalling Technology, F. Hoffmann-LA Roche AG, Merck Millipore, Bio-Rad Laboratories,  and Bio SB, Inc. are the vital key players in the market. These companies are presently focusing on innovation and advancements in their products to remain pertinent in this competitive environment. But their focus is anticipated to shift towards strategic alliances in the upcoming years, in an effort to expand their reach across various countries. The market is further divided on the basis of product, application and application. By product into Antibodies, Equipment, Reagents, Kits. By Application into Diagnostics, Drug Testing. By End-User into Hospital & Diagnostic Laboratories, Research Institutes and Others.

On the idea of geographical distribution, the global Immunohistochemistry market is divided for the key regions such as Asia Pacific, North America, Europe, Latin America and Remainder of the World. North America has been leading and dominating in this market across the world with regards to market share due to the high adoption of IHC instruments in laboratories and diagnostic centres, with the availability of well-established healthcare facilities in the region. Whereas, Asia-Pacific is additionally anticipated to exhibit highest growth rate / CAGR over the forecast period amount, because of the rapidly increasing elderly population and increase in the prevalence of chronic diseases in the countries such as China and India.

See also  Does the smart health device people use today have an element of device bias?

Furthermore, rising regulatory approval and development of novel IHC products are expected to support IHC market expansion. Additionally, the global market for immunohistochemistry is advantaging substantially from the rising prevalence of cancer and various other chronic diseases across the world. Aside from this, the alarming need in the medical and healthcare spending and the shifting focus on value-based healthcare solutions are also supporting the growth of the global market, substantially. Moreover, the increasing uptake of advanced technologies in the medical and healthcare industries is likely to spice up this market over the coming years.

For More Information on the Research Report, refer to below links: –

Global Immunohistochemistry Market Growth

Related Report:-

Tissue Diagnostic Market by Product Type (Consumables and Instruments), by Technology (Immunohistochemistry (IHC), in Situ Hybridization (ISH), Digital Pathology and Workflow Management, and Special Staining), by Diseases (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC), and Others), and by End-users (Hospitals, Research Laboratories, Ambulatory Surgical Centers, Diagnostic Centers, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2026

Contact Us:-

Ken Research

Ankur Gupta, Head Marketing & Communications

[email protected]


Related Posts